These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27341161)

  • 1. Dissemination of a Multidrug-Resistant VIM-1- and CMY-99-Producing Proteus mirabilis Clone in Bulgaria.
    Markovska R; Schneider I; Keuleyan E; Ivanova D; Lesseva M; Stoeva T; Sredkova M; Bauernfeind A; Mitov I
    Microb Drug Resist; 2017 Apr; 23(3):345-350. PubMed ID: 27341161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
    Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
    J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
    Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
    Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis.
    Mata C; Navarro F; Miró E; Walsh TR; Mirelis B; Toleman M
    J Antimicrob Chemother; 2011 Oct; 66(10):2266-70. PubMed ID: 21752830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.
    Protonotariou E; Poulou A; Politi L; Meletis G; Chatzopoulou F; Malousi A; Metallidis S; Tsakris A; Skoura L
    Int J Antimicrob Agents; 2020 Aug; 56(2):106060. PubMed ID: 32574790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.
    Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Pournaras S; Markou F
    J Antimicrob Chemother; 2007 Jul; 60(1):136-9. PubMed ID: 17491004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First report of bla
    Leulmi Z; Kandouli C; Mihoubi I; Benlabed K; Lezzar A; Rolain JM
    J Glob Antimicrob Resist; 2019 Mar; 16():125-129. PubMed ID: 30217548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal dissemination of multilocus sequence type ST15 KPC-2-producing Klebsiella pneumoniae in Bulgaria.
    Markovska R; Stoeva T; Schneider I; Boyanova L; Popova V; Dacheva D; Kaneva R; Bauernfeind A; Mitev V; Mitov I
    APMIS; 2015 Oct; 123(10):887-94. PubMed ID: 26303718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris.
    Mokracka J; Gruszczyńska B; Kaznowski A
    APMIS; 2012 Dec; 120(12):950-8. PubMed ID: 23030307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Transmission of Gram-Negative Bacteria with Carbapenemases NDM-1, VIM-1, and OXA-23/72 in a Bulgarian Hospital.
    Pfeifer Y; Trifonova A; Pietsch M; Brunner M; Todorova I; Gergova I; Wilharm G; Werner G; Savov E
    Microb Drug Resist; 2017 Apr; 23(3):301-307. PubMed ID: 27459019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.
    Vourli S; Tsorlini H; Katsifa H; Polemis M; Tzouvelekis LS; Kontodimou A; Vatopoulos AC
    Clin Microbiol Infect; 2006 Jul; 12(7):691-4. PubMed ID: 16774572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissemination of Multidrug-Resistant Proteus mirabilis Clones Carrying a Novel Integron-Borne
    Ramos AC; Cayô R; Carvalhaes CG; Jové T; da Silva GP; Sancho FMP; Chagas-Neto T; Medeiros EAS; Gales AC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt.
    ElTaweel M; Said HS; Barwa R
    Ann Clin Microbiol Antimicrob; 2024 May; 23(1):46. PubMed ID: 38790053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Genetic Environment of the bla
    Espinal P; Miró E; Ramoneda L; Flores M; Rivera A; Coll P; Navarro F
    Microb Drug Resist; 2017 Oct; 23(7):833-837. PubMed ID: 28304213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Resistance to Carbapenems in
    Bontron S; Poirel L; Kieffer N; Savov E; Trifonova A; Todorova I; Kueffer G; Nordmann P
    Microb Drug Resist; 2019 Jun; 25(5):663-667. PubMed ID: 30676261
    [No Abstract]   [Full Text] [Related]  

  • 16. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region.
    Siebor E; Neuwirth C
    J Antimicrob Chemother; 2011 Nov; 66(11):2513-20. PubMed ID: 21846670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany.
    Lange F; Pfennigwerth N; Gerigk S; Gohlke F; Oberdorfer K; Purr I; Wohanka N; Roggenkamp A; Gatermann SG; Kaase M
    J Antimicrob Chemother; 2017 May; 72(5):1334-1339. PubMed ID: 28093482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Characterization of β-Lactam Resistance and Antimicrobial Susceptibility to Possible Therapeutic Options of AmpC-Producing Multidrug-Resistant
    Rubic Z; Soprek S; Jelic M; Novak A; Goic-Barisic I; Radic M; Tambic-Andrasevic A; Tonkic M
    Microb Drug Resist; 2021 Feb; 27(2):162-169. PubMed ID: 32429775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.